U.S. market Closed. Opens in 2 days 4 hours 10 minutes

SUPN | Supernus Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Revenue607.52M667.24M579.77M520.40M392.75M408.90M302.24M215.00M144.43M122.05M12.02M1.48M803.00K106.00K37.92M8.89M4.23M
Cost of Revenue168.64M87.22M75.06M52.46M16.66M15.36M15.21M11.99M8.42M5.76M1.10MN/AN/AN/AN/AN/AN/A
Gross Profit438.88M580.02M504.71M467.94M376.10M393.54M287.02M203.02M136.00M116.29M10.91M1.48MN/A13.51M46.51M8.89MN/A
Operating Expenses425.48M534.40M425.21M292.34M227.52M249.10M187.48M148.80M118.34M92.06M72.83M43.65MN/A53.63M42.50M34.75MN/A
Selling, General & Admin336.36M377.22M304.76M200.68M158.43M159.89M137.91M106.01M89.20M72.47M55.59M20.13MN/A5.08M4.65M4.29MN/A
Research & Development89.12M74.55M90.47M75.96M69.10M89.21M49.58M42.79M29.14M19.59M17.25M23.52M30.63M35.15M29.26M30.46M19.27M
Other Operating Expenses82.39M82.63M29.99M15.70MN/AN/AN/AN/AN/AN/AN/AN/AN/A13.40M8.59M163.00N/A
Operating Income13.40M67.30M86.03M173.70M148.57M144.44M99.54M54.22M17.66M24.23M-61.92M-42.17M-37.75M-40.12M4.02M-25.86M-19.05M
Other Expenses / Income-10.63M-6.56M-12.85M-5.05M-1.08M-4.27M1.08M-3.85M-2.69M-4.36M-30.35M-4.12M-1.72M649.00K122.00K-7.62M1.77M
Before Tax Income2.77M60.74M73.17M168.65M147.49M140.18M100.62M50.37M14.97M19.87M-92.27M-46.28M-39.47M-39.47M4.14M-33.48M-17.27M
Income Tax Expenses1.45M32.00K19.75M41.70M34.43M29.18M43.33M-40.85M956.00KN/AN/AN/A-16.25M-399.00KN/AN/AN/A
Net Income1.32M60.71M53.42M126.95M113.06M110.99M57.28M91.22M14.02M19.87M-92.27M-46.28M56.00M-38.46M460.00K-33.48M-17.27M
Interest Expenses2.42M7.07M23.42M23.75M22.71M18.11M1.57M5.09M1.23M4.96M7.85M3.58M1.87MN/AN/A8.68MN/A
Basic Shares Outstanding54.54M53.67M53.10M52.62M52.41M54.10M50.76M49.47M47.49M42.26M31.85M17.44M13.86M13.86M13.86M13.86M13.86M
Diluted Shares Outstanding55.51M61.68M54.36M53.69M53.82M54.10M53.30M51.71M51.16M50.58M31.85M17.44M13.86M13.86M13.86M13.86M13.86M
EBITDA98.26M149.93M120.06M210.00M170.19M158.29M110.32M57.86M17.12M25.76M-83.68M-41.84M42.50M-37.67M1.53M-23.69M-16.34M
EBITDA Margin16.17%22.47%20.71%40.35%43.33%38.71%36.50%26.91%11.86%21.11%-696.25%-2,826.89%5,293.03%-35,541.51%4.04%-266.50%-386.02%
EBIT5.18M67.81M96.60M192.40M170.19M158.29M102.19M55.46M16.20M24.83M-84.42M-42.71M41.62M-38.86M460.00K-24.80M-17.27M
EBIT Margin0.85%10.16%16.66%36.97%43.33%38.71%33.81%25.79%11.22%20.35%-702.42%-2,885.74%5,183.56%-36,662.26%1.21%-279.04%-408.04%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙